nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadyl Acetate—Loperamide—CALM1—type 2 diabetes mellitus	0.0365	0.131	CrCbGaD
Methadyl Acetate—Phenoxybenzamine—CALM1—type 2 diabetes mellitus	0.0321	0.115	CrCbGaD
Methadyl Acetate—Promethazine—CALM1—type 2 diabetes mellitus	0.0264	0.0948	CrCbGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—MC4R—type 2 diabetes mellitus	0.0218	0.0302	CbGpPWpGaD
Methadyl Acetate—OPRM1—G-protein activation—GNB3—type 2 diabetes mellitus	0.0205	0.0285	CbGpPWpGaD
Methadyl Acetate—Benzphetamine—ADRA2A—type 2 diabetes mellitus	0.0152	0.0546	CrCbGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—CCKAR—type 2 diabetes mellitus	0.0151	0.0209	CbGpPWpGaD
Methadyl Acetate—Phenoxybenzamine—ADRA2A—type 2 diabetes mellitus	0.0145	0.0522	CrCbGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—HMGA1—type 2 diabetes mellitus	0.0144	0.02	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—AGTR2—type 2 diabetes mellitus	0.0132	0.0183	CbGpPWpGaD
Methadyl Acetate—Propiomazine—HTR2C—type 2 diabetes mellitus	0.0131	0.0469	CrCbGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—EDNRB—type 2 diabetes mellitus	0.0126	0.0175	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—ABCC2—type 2 diabetes mellitus	0.0124	0.0444	CrCbGaD
Methadyl Acetate—Modafinil—CYP1A2—type 2 diabetes mellitus	0.0122	0.0438	CrCbGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—EDNRA—type 2 diabetes mellitus	0.0119	0.0165	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—MTNR1A—type 2 diabetes mellitus	0.0119	0.0165	CbGpPWpGaD
Methadyl Acetate—Disopyramide—CYP3A4—type 2 diabetes mellitus	0.0113	0.0407	CrCbGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1A—type 2 diabetes mellitus	0.011	0.0153	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—MC4R—type 2 diabetes mellitus	0.0102	0.0142	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1A—type 2 diabetes mellitus	0.00945	0.0131	CbGpPWpGaD
Methadyl Acetate—Levomethadyl Acetate—CYP3A4—type 2 diabetes mellitus	0.00923	0.0332	CrCbGaD
Methadyl Acetate—Tamoxifen—CYP2E1—type 2 diabetes mellitus	0.00867	0.0311	CrCbGaD
Methadyl Acetate—OPRM1—Opioid Signalling—GNB3—type 2 diabetes mellitus	0.00853	0.0118	CbGpPWpGaD
Methadyl Acetate—Diphenhydramine—CYP1A2—type 2 diabetes mellitus	0.00847	0.0304	CrCbGaD
Methadyl Acetate—Orphenadrine—CYP2E1—type 2 diabetes mellitus	0.00842	0.0302	CrCbGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—BCL2L1—type 2 diabetes mellitus	0.00828	0.0115	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—CYP1A2—type 2 diabetes mellitus	0.00825	0.0296	CrCbGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IRS2—type 2 diabetes mellitus	0.00823	0.0114	CbGpPWpGaD
Methadyl Acetate—Methadone—CYP1A2—type 2 diabetes mellitus	0.00818	0.0294	CrCbGaD
Methadyl Acetate—Modafinil—CYP3A4—type 2 diabetes mellitus	0.00807	0.029	CrCbGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—MC4R—type 2 diabetes mellitus	0.00802	0.0111	CbGpPWpGaD
Methadyl Acetate—Dextropropoxyphene—CYP3A4—type 2 diabetes mellitus	0.00798	0.0287	CrCbGaD
Methadyl Acetate—OPRM1—Peptide GPCRs—CCR5—type 2 diabetes mellitus	0.00769	0.0107	CbGpPWpGaD
Methadyl Acetate—Loperamide—CYP3A4—type 2 diabetes mellitus	0.0076	0.0273	CrCbGaD
Methadyl Acetate—OPRM1—Opioid Signalling—ADCY5—type 2 diabetes mellitus	0.0076	0.0105	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—PPP2CA—type 2 diabetes mellitus	0.00728	0.0101	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—MTNR1A—type 2 diabetes mellitus	0.0072	0.00998	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—IRS1—type 2 diabetes mellitus	0.00719	0.00996	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCKAR—type 2 diabetes mellitus	0.0071	0.00984	CbGpPWpGaD
Methadyl Acetate—Benzphetamine—CYP3A4—type 2 diabetes mellitus	0.007	0.0251	CrCbGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—MC4R—type 2 diabetes mellitus	0.00687	0.00952	CbGpPWpGaD
Methadyl Acetate—Phenoxybenzamine—CYP3A4—type 2 diabetes mellitus	0.00669	0.024	CrCbGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—CCR5—type 2 diabetes mellitus	0.00657	0.00911	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB3—type 2 diabetes mellitus	0.00656	0.0091	CbGpPWpGaD
Methadyl Acetate—OPRM1—Opioid Signalling—CALM1—type 2 diabetes mellitus	0.00653	0.00905	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—FAS—type 2 diabetes mellitus	0.00652	0.00903	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—MTNR1B—type 2 diabetes mellitus	0.00625	0.00866	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GCGR—type 2 diabetes mellitus	0.00621	0.00861	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—AGTR2—type 2 diabetes mellitus	0.0062	0.0086	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—PIK3R1—type 2 diabetes mellitus	0.00604	0.00837	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—EDNRB—type 2 diabetes mellitus	0.00594	0.00824	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—MTNR1B—type 2 diabetes mellitus	0.0058	0.00803	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GIPR—type 2 diabetes mellitus	0.00572	0.00793	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB3—type 2 diabetes mellitus	0.00562	0.00779	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—EDNRA—type 2 diabetes mellitus	0.00561	0.00778	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCKAR—type 2 diabetes mellitus	0.00556	0.0077	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—GHRL—type 2 diabetes mellitus	0.00547	0.00758	CbGpPWpGaD
Methadyl Acetate—Tamoxifen—CYP3A4—type 2 diabetes mellitus	0.00546	0.0196	CrCbGaD
Methadyl Acetate—Methadone—CYP3A4—type 2 diabetes mellitus	0.00541	0.0194	CrCbGaD
Methadyl Acetate—Orphenadrine—CYP3A4—type 2 diabetes mellitus	0.0053	0.019	CrCbGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—AGTR2—type 2 diabetes mellitus	0.00523	0.00725	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—MC4R—type 2 diabetes mellitus	0.00523	0.00725	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GIP—type 2 diabetes mellitus	0.00503	0.00698	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—type 2 diabetes mellitus	0.00497	0.00688	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—type 2 diabetes mellitus	0.00486	0.00673	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCKAR—type 2 diabetes mellitus	0.00476	0.0066	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRB—type 2 diabetes mellitus	0.00465	0.00645	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—ADRA2A—type 2 diabetes mellitus	0.00463	0.00642	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—type 2 diabetes mellitus	0.00452	0.00626	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—PIK3R1—type 2 diabetes mellitus	0.00448	0.00621	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—EDNRA—type 2 diabetes mellitus	0.00439	0.00609	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—type 2 diabetes mellitus	0.0043	0.00596	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—ADRB3—type 2 diabetes mellitus	0.00428	0.00593	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—AVP—type 2 diabetes mellitus	0.00425	0.00589	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—RELA—type 2 diabetes mellitus	0.00422	0.00585	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—type 2 diabetes mellitus	0.00416	0.00577	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CRHR1—type 2 diabetes mellitus	0.00413	0.00573	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—MTNR1A—type 2 diabetes mellitus	0.00407	0.00564	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—EDN1—type 2 diabetes mellitus	0.00404	0.00561	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRB—type 2 diabetes mellitus	0.00399	0.00552	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—type 2 diabetes mellitus	0.00387	0.00536	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—MTNR1B—type 2 diabetes mellitus	0.00378	0.00524	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDNRA—type 2 diabetes mellitus	0.00376	0.00522	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MTNR1A—type 2 diabetes mellitus	0.00369	0.00512	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GLP1R—type 2 diabetes mellitus	0.00369	0.00511	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—type 2 diabetes mellitus	0.00368	0.0051	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—GHRL—type 2 diabetes mellitus	0.00367	0.00508	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—GNB3—type 2 diabetes mellitus	0.00364	0.00504	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCKAR—type 2 diabetes mellitus	0.00363	0.00503	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCR5—type 2 diabetes mellitus	0.00362	0.00501	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—NFKB1—type 2 diabetes mellitus	0.00356	0.00493	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—C3—type 2 diabetes mellitus	0.00353	0.0049	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GCGR—type 2 diabetes mellitus	0.00351	0.00487	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—AGT—type 2 diabetes mellitus	0.00336	0.00465	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—IAPP—type 2 diabetes mellitus	0.00326	0.00452	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—ADCY5—type 2 diabetes mellitus	0.00324	0.00449	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GIPR—type 2 diabetes mellitus	0.00323	0.00448	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GRK5—type 2 diabetes mellitus	0.00323	0.00448	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GCGR—type 2 diabetes mellitus	0.00319	0.00442	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AGTR2—type 2 diabetes mellitus	0.00317	0.00439	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—CCR5—type 2 diabetes mellitus	0.00305	0.00423	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—EDNRB—type 2 diabetes mellitus	0.00303	0.00421	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ARAP1—type 2 diabetes mellitus	0.00302	0.00418	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—C3—type 2 diabetes mellitus	0.00298	0.00413	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—TGFB1—type 2 diabetes mellitus	0.00296	0.00411	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—MC4R—type 2 diabetes mellitus	0.00296	0.0041	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—HTR2C—type 2 diabetes mellitus	0.00295	0.00408	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GRK5—type 2 diabetes mellitus	0.00293	0.00407	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GIPR—type 2 diabetes mellitus	0.00293	0.00407	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—EDNRA—type 2 diabetes mellitus	0.00287	0.00397	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AVP—type 2 diabetes mellitus	0.00285	0.00395	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GIP—type 2 diabetes mellitus	0.00285	0.00394	CbGpPWpGaD
Methadyl Acetate—OPRM1—G alpha (i) signalling events—AGT—type 2 diabetes mellitus	0.00283	0.00393	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—type 2 diabetes mellitus	0.00283	0.00392	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—ADRA2A—type 2 diabetes mellitus	0.0028	0.00389	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GHRL—type 2 diabetes mellitus	0.00279	0.00387	CbGpPWpGaD
Methadyl Acetate—OPRM1—IL4-mediated signaling events—AKT1—type 2 diabetes mellitus	0.00277	0.00385	CbGpPWpGaD
Methadyl Acetate—OPRM1—Peptide ligand-binding receptors—CCL2—type 2 diabetes mellitus	0.00276	0.00383	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VPS26A—type 2 diabetes mellitus	0.00276	0.00383	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CALCA—type 2 diabetes mellitus	0.00276	0.00382	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	0.00271	0.00376	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MC4R—type 2 diabetes mellitus	0.00268	0.00372	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GIP—type 2 diabetes mellitus	0.00258	0.00358	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GCG—type 2 diabetes mellitus	0.00255	0.00354	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	0.00243	0.00336	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	0.00242	0.00335	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	0.00237	0.00328	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	0.00234	0.00324	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	0.00225	0.00312	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—IL6—type 2 diabetes mellitus	0.00223	0.00309	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.0022	0.00305	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.0022	0.00305	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.00218	0.00302	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.00217	0.00301	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.00214	0.00296	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.00212	0.00294	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.00208	0.00289	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.00207	0.00286	CbGpPWpGaD
Methadyl Acetate—OPRM1—TCR Signaling Pathway—AKT1—type 2 diabetes mellitus	0.00206	0.00285	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.00205	0.00284	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.00194	0.00269	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.00189	0.00262	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.00188	0.00261	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.00186	0.00258	CbGpPWpGaD
Methadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.00185	0.00257	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.00185	0.00256	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.00184	0.00256	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.0018	0.0025	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.0018	0.0025	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.00179	0.00248	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.00173	0.0024	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.00173	0.0024	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.00171	0.00238	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.00171	0.00238	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.00168	0.00232	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.00166	0.00231	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.00164	0.00227	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.00163	0.00225	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.00162	0.00224	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.00159	0.0022	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.00158	0.0022	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.00158	0.00219	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.00156	0.00216	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.00156	0.00216	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.00153	0.00212	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.00151	0.0021	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.00147	0.00204	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.00145	0.00201	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.00144	0.002	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.00144	0.00199	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.00143	0.00199	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.00142	0.00197	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.00142	0.00196	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.00141	0.00196	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.00139	0.00192	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.00135	0.00187	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.00131	0.00182	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.0013	0.0018	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.00129	0.00179	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.00125	0.00174	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.00124	0.00172	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.00123	0.0017	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.00117	0.00162	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.00116	0.0016	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.00115	0.00159	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.00115	0.00159	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.00113	0.00157	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00112	0.00155	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00112	0.00155	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.00111	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.00111	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.00111	0.00154	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.0011	0.00152	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.00106	0.00147	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.00104	0.00145	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.00102	0.00141	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.00101	0.0014	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000996	0.00138	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.00099	0.00137	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000984	0.00136	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000969	0.00134	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000966	0.00134	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000965	0.00134	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000961	0.00133	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000948	0.00131	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000926	0.00128	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.00092	0.00128	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000895	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000893	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000893	0.00124	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.00088	0.00122	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000869	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.000865	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.000865	0.0012	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.00085	0.00118	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000847	0.00117	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000847	0.00117	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000836	0.00116	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000813	0.00113	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000788	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000784	0.00109	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000774	0.00107	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000774	0.00107	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000762	0.00106	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000759	0.00105	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000725	0.001	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000712	0.000987	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000711	0.000986	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000674	0.000934	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000667	0.000925	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000658	0.000913	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000658	0.000913	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000656	0.000909	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000653	0.000905	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000646	0.000895	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000636	0.000882	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000634	0.000879	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000626	0.000868	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000608	0.000842	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000595	0.000825	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.00057	0.00079	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.00056	0.000776	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—C3—type 2 diabetes mellitus	0.000547	0.000758	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000522	0.000723	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.00052	0.000721	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	0.00052	0.000721	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000511	0.000708	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000509	0.000706	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000509	0.000706	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.000503	0.000698	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.00048	0.000666	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000454	0.00063	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	0.000435	0.000603	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000428	0.000593	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000421	0.000583	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000421	0.000583	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000419	0.00058	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.0004	0.000554	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000382	0.000529	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000382	0.000529	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	0.000359	0.000498	CbGpPWpGaD
Methadyl Acetate—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	0.000327	0.000453	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	0.000324	0.000449	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	0.000322	0.000446	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	0.000306	0.000424	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	0.000303	0.00042	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	0.000297	0.000412	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	0.000282	0.000391	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	0.000275	0.000381	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	0.000252	0.00035	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	0.000247	0.000343	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	0.00019	0.000264	CbGpPWpGaD
Methadyl Acetate—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	0.000175	0.000243	CbGpPWpGaD
